Hypoactive Sexual Desire Disorder (HSDD) and Low Libido

One term used in clinical settings is Hypoactive Sexual Desire Disorder (HSDD). This diagnosis refers to a persistent decrease in sexual desire that causes personal distress and cannot be explained by another medical or relationship condition alone.

If you are experiencing changes that concern you, you are not alone.

What Symptoms May Be Present?

HSDD and related concerns may include:

• Decreased sexual desire

• Reduced arousal

• Less intense or more difficult orgasm

• Reduced pleasure or responsiveness

• Emotional distress related to intimacy

Studies suggest that a substantial percentage of perimenopausal and postmenopausal women report at least one of these concerns during the menopausal transition.

Every woman’s experience is different. Distress — not just reduced desire — is a key part of the diagnosis.

What Contributes to Low Libido?

Sexual desire is influenced by many factors, including:

Hormonal Changes

• Declining estrogen

• Changes in testosterone levels

• Vaginal dryness or discomfort

Physical Health

• Chronic illness

• Cancer treatments

• Fatigue

• Pain with intercourse

• Certain medications such as SSRIs or some blood pressure medications

Emotional and Relationship Factors

• Stress

• Body image changes

• Cultural or religious influences

• Relationship dynamics

• Sleep disturbances

Because desire is multifactorial, evaluation must be individualized.

What Are Potential Treatment Approaches?

Management depends on the underlying contributors and may include:

• Addressing vaginal dryness with moisturizers or lubricants

• Pelvic floor physical therapy

• Counseling or sex therapy

• Reviewing medications that may affect libido

• Lifestyle modifications to improve sleep and stress

• Evaluating hormone levels when appropriate

• Considering medical therapies based on individual risk assessment

Some clinicians may discuss testosterone therapy in select cases; however, in the United States, there is currently no FDA-approved testosterone formulation specifically indicated for HSDD in women. Treatment decisions should be made carefully and under medical supervision.

Intravaginal DHEA and other therapies have also been studied, though research is ongoing.

There is no one-size-fits-all solution. A comprehensive evaluation helps determine what options may be appropriate.

When to Seek Evaluation

If changes in sexual desire or intimacy are causing personal distress, consider scheduling a consultation to review your symptoms, health history, and goals.

Sexual health is an important part of overall wellness and deserves thoughtful, evidence-based discussion.

Educational Disclaimer

This content is provided for educational purposes only and does not constitute medical advice. Treatment decisions should be made in consultation with a qualified healthcare professional.